DOAC-associated traumatic intracranial hemorrhage reversal approach.

Enhance your trauma care skills with the Platinum Trauma Exam. Use flashcards and multiple-choice questions with hints and explanations. Prepare now!

Multiple Choice

DOAC-associated traumatic intracranial hemorrhage reversal approach.

In this situation the key idea is rapid reversal of the DOAC to limit bleeding and hematoma expansion in intracranial hemorrhage. If the patient is on a Factor Xa inhibitor (such as apixaban, rivaroxaban, or edoxaban), the best option is an agent that directly neutralizes the drug—andexanet alfa. If the patient is on dabigatran, idarucizumab is the specific reversal agent. When these DOAC-specific antidotes aren’t available, a four-factor PCC can be considered to help restore clotting factors and promote hemostasis. Expedite neurosurgical assessment because imaging and clinical status will guide whether surgical intervention or other rapid measures are needed to control the hemorrhage and reduce damage. It’s important to recognize that vitamins like Vitamin K and treatments such as high-dose corticosteroids do not reverse DOACs and are not appropriate for reversing DOAC-associated intracranial hemorrhage.

In this situation the key idea is rapid reversal of the DOAC to limit bleeding and hematoma expansion in intracranial hemorrhage. If the patient is on a Factor Xa inhibitor (such as apixaban, rivaroxaban, or edoxaban), the best option is an agent that directly neutralizes the drug—andexanet alfa. If the patient is on dabigatran, idarucizumab is the specific reversal agent. When these DOAC-specific antidotes aren’t available, a four-factor PCC can be considered to help restore clotting factors and promote hemostasis.

Expedite neurosurgical assessment because imaging and clinical status will guide whether surgical intervention or other rapid measures are needed to control the hemorrhage and reduce damage. It’s important to recognize that vitamins like Vitamin K and treatments such as high-dose corticosteroids do not reverse DOACs and are not appropriate for reversing DOAC-associated intracranial hemorrhage.

More practice questions